Cargando…
Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medica...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296233/ https://www.ncbi.nlm.nih.gov/pubmed/35875823 http://dx.doi.org/10.1016/j.jksus.2022.102226 |
_version_ | 1784750227258867712 |
---|---|
author | Chtita, Samir Belaidi, Salah Qais, Faizan Abul Ouassaf, Mebarka AlMogren, Muneerah Mogren Al-Zahrani, Ateyah A. Bakhouch, Mohamed Belhassan, Assia Zaki, Hanane Bouachrine, Mohammed Lakhlifi, Tahar |
author_facet | Chtita, Samir Belaidi, Salah Qais, Faizan Abul Ouassaf, Mebarka AlMogren, Muneerah Mogren Al-Zahrani, Ateyah A. Bakhouch, Mohamed Belhassan, Assia Zaki, Hanane Bouachrine, Mohammed Lakhlifi, Tahar |
author_sort | Chtita, Samir |
collection | PubMed |
description | COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medications and drug treatments. There are no approved drugs available to treat COVID-19 yet, although several vaccine candidates are already available and some of them are listed for emergency use by the world health organization (WHO). Identifying a potential drug candidate may make a significant contribution to control the expansion of COVID-19. The in vitro biological activity of asymmetric disulfides against coronavirus through the inhibition of SARS-CoV-2 main protease (Mpro) protein was reported. Due to the lack of convincing evidence those asymmetric disulfides have favorable pharmacological properties for the clinical treatment of Coronavirus, in silico evaluation should be performed to assess the potential of these compounds to inhibit the SARS-CoV-2 Mpro. In this context, we report herein the molecular docking for a series of 40 unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitor. The optimal binding features of disulfides within the binding pocket of SARS-CoV-2 endoribonuclease protein (Protein Data Bank [PDB]: 6LU7) was described. Studied compounds were ranked for potential effectiveness, and those have shown high molecular docking scores were proposed as novel drug candidates against SARS-CoV-2. Moreover, the outcomes of drug similarity and ADME (Absorption, Distribution, Metabolism, and Excretion) analyses have may have the effectiveness of acting as medicines, and would be of interest as promising starting point for designing compounds against SARS-CoV-2. Finally, the stability of these three compounds in the complex with Mpro was validated through molecular dynamics (MD) simulation, in which they displayed stable trajectory and molecular properties with a consistent interaction profile. |
format | Online Article Text |
id | pubmed-9296233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier B.V. on behalf of King Saud University. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92962332022-07-20 Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations Chtita, Samir Belaidi, Salah Qais, Faizan Abul Ouassaf, Mebarka AlMogren, Muneerah Mogren Al-Zahrani, Ateyah A. Bakhouch, Mohamed Belhassan, Assia Zaki, Hanane Bouachrine, Mohammed Lakhlifi, Tahar J King Saud Univ Sci Original Article COVID-19 pandemic caused by very severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) agent is an ongoing major global health concern. The disease has caused more than 452 million affected cases and more than 6 million death worldwide. Hence, there is an urgency to search for possible medications and drug treatments. There are no approved drugs available to treat COVID-19 yet, although several vaccine candidates are already available and some of them are listed for emergency use by the world health organization (WHO). Identifying a potential drug candidate may make a significant contribution to control the expansion of COVID-19. The in vitro biological activity of asymmetric disulfides against coronavirus through the inhibition of SARS-CoV-2 main protease (Mpro) protein was reported. Due to the lack of convincing evidence those asymmetric disulfides have favorable pharmacological properties for the clinical treatment of Coronavirus, in silico evaluation should be performed to assess the potential of these compounds to inhibit the SARS-CoV-2 Mpro. In this context, we report herein the molecular docking for a series of 40 unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitor. The optimal binding features of disulfides within the binding pocket of SARS-CoV-2 endoribonuclease protein (Protein Data Bank [PDB]: 6LU7) was described. Studied compounds were ranked for potential effectiveness, and those have shown high molecular docking scores were proposed as novel drug candidates against SARS-CoV-2. Moreover, the outcomes of drug similarity and ADME (Absorption, Distribution, Metabolism, and Excretion) analyses have may have the effectiveness of acting as medicines, and would be of interest as promising starting point for designing compounds against SARS-CoV-2. Finally, the stability of these three compounds in the complex with Mpro was validated through molecular dynamics (MD) simulation, in which they displayed stable trajectory and molecular properties with a consistent interaction profile. The Author(s). Published by Elsevier B.V. on behalf of King Saud University. 2022-10 2022-07-20 /pmc/articles/PMC9296233/ /pubmed/35875823 http://dx.doi.org/10.1016/j.jksus.2022.102226 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Chtita, Samir Belaidi, Salah Qais, Faizan Abul Ouassaf, Mebarka AlMogren, Muneerah Mogren Al-Zahrani, Ateyah A. Bakhouch, Mohamed Belhassan, Assia Zaki, Hanane Bouachrine, Mohammed Lakhlifi, Tahar Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title | Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title_full | Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title_fullStr | Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title_full_unstemmed | Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title_short | Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations |
title_sort | unsymmetrical aromatic disulfides as sars-cov-2 mpro inhibitors: molecular docking, molecular dynamics, and adme scoring investigations |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296233/ https://www.ncbi.nlm.nih.gov/pubmed/35875823 http://dx.doi.org/10.1016/j.jksus.2022.102226 |
work_keys_str_mv | AT chtitasamir unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT belaidisalah unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT qaisfaizanabul unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT ouassafmebarka unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT almogrenmuneerahmogren unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT alzahraniateyaha unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT bakhouchmohamed unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT belhassanassia unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT zakihanane unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT bouachrinemohammed unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations AT lakhlifitahar unsymmetricalaromaticdisulfidesassarscov2mproinhibitorsmoleculardockingmoleculardynamicsandadmescoringinvestigations |